Risk Manag Healthc Policy. 2025 Sep 12;18:3017-3028. doi: 10.2147/RMHP.S533705. eCollection 2025. ABSTRACT OBJECTIVE: This study aims to investigate the clinical […]
Immunol Res. 2025 Sep 19;73(1):134. doi: 10.1007/s12026-025-09693-8. NO ABSTRACT PMID:40971009 | DOI:10.1007/s12026-025-09693-8
Front Cell Infect Microbiol. 2025 Sep 3;15:1607798. doi: 10.3389/fcimb.2025.1607798. eCollection 2025. ABSTRACT INTRODUCTION: Diabetes mellitus (DM), a globally prevalent chronic
Rheumatol Ther. 2025 Sep 19. doi: 10.1007/s40744-025-00794-2. Online ahead of print. ABSTRACT INTRODUCTION: Gout is an inflammatory arthritis that, when
Front Nutr. 2025 Sep 3;12:1658896. doi: 10.3389/fnut.2025.1658896. eCollection 2025. ABSTRACT OBJECTIVES: Malnutrition and systemic inflammation are common in critically ill
Dermatol Ther (Heidelb). 2025 Sep 19. doi: 10.1007/s13555-025-01540-w. Online ahead of print. ABSTRACT INTRODUCTION: In China, real-world evidence on the
Front Med (Lausanne). 2025 Sep 3;12:1632514. doi: 10.3389/fmed.2025.1632514. eCollection 2025. ABSTRACT Although lymphoma involving the adrenal gland is uncommon, it
J Racial Ethn Health Disparities. 2025 Sep 19. doi: 10.1007/s40615-025-02668-3. Online ahead of print. ABSTRACT American Indian and Alaska Native
Front Med (Lausanne). 2025 Sep 3;12:1579182. doi: 10.3389/fmed.2025.1579182. eCollection 2025. ABSTRACT Castleman’s disease (CD) consists of a wide spectrum of
Clin Exp Nephrol. 2025 Sep 19. doi: 10.1007/s10157-025-02758-w. Online ahead of print. ABSTRACT BACKGROUND: Comprehensive epidemiological information regarding Alport syndrome,
Cureus. 2025 Aug 17;17(8):e90354. doi: 10.7759/cureus.90354. eCollection 2025 Aug. ABSTRACT OBJECTIVE: To evaluate the efficacy and safety of 5-aminolevulinic acid
Cureus. 2025 Aug 18;17(8):e90362. doi: 10.7759/cureus.90362. eCollection 2025 Aug. ABSTRACT The occurrence of digital necrosis and Raynaud’s phenomenon with anticentromere
Front Cell Dev Biol. 2025 Sep 3;13:1658089. doi: 10.3389/fcell.2025.1658089. eCollection 2025. ABSTRACT Sinomenine (SIN) is the key bioactive alkaloid isolated
Neurourol Urodyn. 2025 Sep 19. doi: 10.1002/nau.70151. Online ahead of print. NO ABSTRACT PMID:40970300 | DOI:10.1002/nau.70151
Sci Rep. 2025 Sep 18;15(1):32612. doi: 10.1038/s41598-025-20259-4. ABSTRACT Adherence to antiretroviral therapy (ART) and maintaining an undetectable maternal HIV viral
Nat Commun. 2025 Sep 18;16(1):8319. doi: 10.1038/s41467-025-63911-3. ABSTRACT Mammals tightly regulate their core body temperature, yet how cells sense and
Eye (Lond). 2025 Sep 18. doi: 10.1038/s41433-025-03973-1. Online ahead of print. NO ABSTRACT PMID:40968152 | DOI:10.1038/s41433-025-03973-1
Intern Med. 2025 Sep 18. doi: 10.2169/internalmedicine.5894-25. Online ahead of print. ABSTRACT Objective In the real-world clinical setting of transplant-eligible
Gut. 2025 Sep 18:gutjnl-2025-336942. doi: 10.1136/gutjnl-2025-336942. Online ahead of print. NO ABSTRACT PMID:40967831 | DOI:10.1136/gutjnl-2025-336942
Chin J Traumatol. 2025 Sep 9:S1008-1275(25)00111-7. doi: 10.1016/j.cjtee.2025.08.003. Online ahead of print. ABSTRACT PURPOSE: End-stage knee osteoarthritis (OA) patients are
BMJ Case Rep. 2025 Sep 17;18(9):e266110. doi: 10.1136/bcr-2025-266110. ABSTRACT Tocilizumab, an interleukin-6 (IL-6) receptor antagonist, is widely used for inflammatory
Joint Bone Spine. 2025 Sep 16:105969. doi: 10.1016/j.jbspin.2025.105969. Online ahead of print. NO ABSTRACT PMID:40967335 | DOI:10.1016/j.jbspin.2025.105969
J Affect Disord. 2025 Sep 16:120340. doi: 10.1016/j.jad.2025.120340. Online ahead of print. ABSTRACT BACKGROUND: Fibromyalgia syndrome (FM) is a prevalent
BMJ Case Rep. 2025 Sep 17;18(9):e266536. doi: 10.1136/bcr-2025-266536. ABSTRACT This case report discusses a patient in his late 30s with
J Autoimmun. 2025 Sep 17;157:103484. doi: 10.1016/j.jaut.2025.103484. Online ahead of print. ABSTRACT Rheumatoid arthritis (RA) is a chronic systemic autoimmune
ESMO Open. 2025 Sep 17;10(10):105796. doi: 10.1016/j.esmoop.2025.105796. Online ahead of print. ABSTRACT BACKGROUND: The conventional drug development pathway in oncology,
Oral Oncol. 2025 Sep 17;169:107688. doi: 10.1016/j.oraloncology.2025.107688. Online ahead of print. ABSTRACT BACKGROUND: Adenoid cystic carcinoma (ACC) is a malignancy
